Eton Pharmaceuticals, Inc. (ETON) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Eton Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -98.89x | -90.22x | -120.01x | -7.86x | -55.31x | -6.11x |
| P/B Ratio | 17.40x | 14.12x | 7.26x | 5.42x | 6.13x | 10.91x |
| P/S Ratio | 5.69x | 8.84x | 3.55x | 3.34x | 4.95x | 4379.78x |
| Profitability | ||||||
| Gross Margin | 53.5% | 60.0% | 66.6% | 67.4% | 88.0% | -633.3% |
| Operating Margin | 0.1% | -6.7% | -3.8% | -38.9% | -6.8% | -69515.4% |
| Net Margin | -5.8% | -9.8% | -3.0% | -42.4% | -9.0% | -71717.9% |
| EBITDA Margin | 5.1% | -3.7% | -0.9% | -30.5% | -4.7% | -67846.2% |
| Liquidity | ||||||
| Current Ratio | 1.57x | 2.06x | 1.65x | 3.10x | 5.18x | 6.51x |
| Quick Ratio | 1.17x | 1.29x | 1.60x | 3.01x | 5.06x | 6.18x |
| Leverage | ||||||
| Debt/Equity | 1.19x | 1.22x | 0.35x | 0.50x | 0.38x | 0.46x |
YoY = year-over-year change. Source: FMP..